mTOR signaling and its roles in normal and abnormal brain development
- PMID: 24795562
- PMCID: PMC4005960
- DOI: 10.3389/fnmol.2014.00028
mTOR signaling and its roles in normal and abnormal brain development
Abstract
Target of rapamycin (TOR) was first identified in yeast as a target molecule of rapamycin, an anti-fugal and immunosuppressant macrolide compound. In mammals, its orthologue is called mammalian TOR (mTOR). mTOR is a serine/threonine kinase that converges different extracellular stimuli, such as nutrients and growth factors, and diverges into several biochemical reactions, including translation, autophagy, transcription, and lipid synthesis among others. These biochemical reactions govern cell growth and cause cells to attain an anabolic state. Thus, the disruption of mTOR signaling is implicated in a wide array of diseases such as cancer, diabetes, and obesity. In the central nervous system, the mTOR signaling cascade is activated by nutrients, neurotrophic factors, and neurotransmitters that enhances protein (and possibly lipid) synthesis and suppresses autophagy. These processes contribute to normal neuronal growth by promoting their differentiation, neurite elongation and branching, and synaptic formation during development. Therefore, disruption of mTOR signaling may cause neuronal degeneration and abnormal neural development. While reduced mTOR signaling is associated with neurodegeneration, excess activation of mTOR signaling causes abnormal development of neurons and glia, leading to brain malformation. In this review, we first introduce the current state of molecular knowledge of mTOR complexes and signaling in general. We then describe mTOR activation in neurons, which leads to translational enhancement, and finally discuss the link between mTOR and normal/abnormal neuronal growth during development.
Keywords: BDNF; CNS neurons; TSC/mTOR; amino acids; brain malformation; mTORC1 signaling; protein synthesis; translational control.
Figures
Similar articles
-
A possible link between BDNF and mTOR in control of food intake.Front Psychol. 2014 Sep 25;5:1093. doi: 10.3389/fpsyg.2014.01093. eCollection 2014. Front Psychol. 2014. PMID: 25309497 Free PMC article. Review.
-
Monitoring mammalian target of rapamycin (mTOR) activity.Methods Enzymol. 2009;452:165-80. doi: 10.1016/S0076-6879(08)03611-2. Methods Enzymol. 2009. PMID: 19200882
-
Mechanistic Target of Rapamycin Signaling Activation Antagonizes Autophagy To Facilitate Zika Virus Replication.J Virol. 2020 Oct 27;94(22):e01575-20. doi: 10.1128/JVI.01575-20. Print 2020 Oct 27. J Virol. 2020. PMID: 32878890 Free PMC article.
-
mTOR in Brain Physiology and Pathologies.Physiol Rev. 2015 Oct;95(4):1157-87. doi: 10.1152/physrev.00038.2014. Physiol Rev. 2015. PMID: 26269525 Review.
-
Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Oxid Med Cell Longev. 2010 Nov-Dec;3(6):374-91. doi: 10.4161/oxim.3.6.14787. Epub 2010 Nov 1. Oxid Med Cell Longev. 2010. PMID: 21307646 Free PMC article. Review.
Cited by
-
Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.Mol Psychiatry. 2022 Jun;27(6):2689-2699. doi: 10.1038/s41380-022-01520-y. Epub 2022 Mar 30. Mol Psychiatry. 2022. PMID: 35354926 Free PMC article. Review.
-
Current concepts in the neuropathogenesis of mucolipidosis type IV.J Neurochem. 2019 Mar;148(5):669-689. doi: 10.1111/jnc.14462. Epub 2018 Aug 30. J Neurochem. 2019. PMID: 29770442 Free PMC article. Review.
-
Insights into epileptogenesis from post-traumatic epilepsy.Nat Rev Neurol. 2024 May;20(5):298-312. doi: 10.1038/s41582-024-00954-y. Epub 2024 Apr 3. Nat Rev Neurol. 2024. PMID: 38570704 Review.
-
New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.Br J Clin Pharmacol. 2016 Nov;82(5):1280-1290. doi: 10.1111/bcp.12845. Epub 2016 Jan 8. Br J Clin Pharmacol. 2016. PMID: 26613210 Free PMC article. Review.
-
Role of mammalian target of rapamycin signaling in autophagy and the neurodegenerative process using a senescence accelerated mouse-prone 8 model.Exp Ther Med. 2017 Aug;14(2):1051-1057. doi: 10.3892/etm.2017.4618. Epub 2017 Jun 15. Exp Ther Med. 2017. PMID: 28810557 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
